DRTG(SH:600329)2014-04-29 16:00Financial Performance - Net profit attributable to shareholders decreased by 13.61% to CNY 102,341,066.16 year-on-year[8] - Operating income increased by 7.09% to CNY 1,551,834,892.58 compared to the same period last year[8] - Basic earnings per share decreased by 12.50% to CNY 0.14[8] - Net profit for Q1 2014 was CNY 109,409,836.67, a decrease of 10.0% from CNY 121,912,657.66 in Q1 2013[26] - Earnings per share for Q1 2014 were CNY 0.14, down from CNY 0.16 in Q1 2013[26] - The company reported a total comprehensive income of CNY 110,287,271.36 for Q1 2014, compared to CNY 121,177,857.52 in Q1 2013[26] Assets and Liabilities - Total assets decreased by 2.13% to CNY 5,150,298,934.70 compared to the end of the previous year[8] - Total assets at the end of Q1 2014 were CNY 4,367,629,930.60, a decrease from CNY 4,466,742,054.36 at the beginning of the year[23] - Total liabilities at the end of Q1 2014 were CNY 1,877,410,228.36, down from CNY 2,084,530,731.15 at the beginning of the year[23] - Shareholders' equity at the end of Q1 2014 was CNY 2,490,219,702.24, an increase from CNY 2,382,211,323.21 at the beginning of the year[23] Cash Flow - Net cash flow from operating activities decreased significantly by 78.18% to CNY 15,570,487.18[8] - Net cash flow from operating activities decreased to RMB 15,570,487.18 from RMB 71,360,742.68, reflecting a decline of 78.2%[32] - Cash inflow from investment activities was RMB 2,879,289,916.98, significantly higher than RMB 129,544.34 in the previous period[32] - Cash outflow for investment activities totaled RMB 2,872,780,088.74, compared to RMB 7,738,646.24 previously, indicating a substantial increase in investment activity[32] - Net cash flow from financing activities showed a significant outflow of -¥256,128,741.79 compared to an inflow of ¥30,604,304.39, primarily due to increased net repayments of borrowings[13] - Total cash and cash equivalents at the end of the period were RMB 425,229,492.70, down from RMB 439,050,195.93[33] Shareholder Information - The total number of shareholders reached 42,533[10] - The largest shareholder, Tianjin Pharmaceutical Group Co., Ltd., holds 44.043% of the shares[10] Government Subsidies and Other Income - The company received government subsidies amounting to CNY 1,625,388.09 related to its core business[8] - Other income increased by 95% to ¥2,074,122.68 from ¥1,065,307.73, mainly due to an increase in government subsidies[13] Operating Costs and Expenses - Operating costs for Q1 2014 were CNY 1,443,619,215.30, up 8.5% from CNY 1,330,099,292.34 in the same period last year[26] - Other expenses surged by 326% to ¥733,911.93 from ¥172,464.04, primarily due to increased donation expenses[13] Compliance and Governance - The company maintained compliance with commitments regarding related party transactions and competition avoidance, ensuring fair market practices[15]